BioAdvance News Phrase Health Portfolio News

Phrase Health Awarded Phase 2 NIH Grant To Scale Quality Improvement Platform

By WebmasterAugust 31, 2021November 1st, 2024No Comments

Phrase Health Awarded Phase 2 NIH Grant To Scale Quality Improvement Platform

The $1.7 million Phase 2 STTR grant expands upon the quality improvement and informatics cloud-based software developed by the company

Previous PostRenovacor Inc. Closes Its Business Combination with Chardan Healthcare Acquisition 2 Corp. and Will Begin Trading on the New York Stock Exchange
Next PostImmunoGenesis Announces Positive Preclinical Glioblastoma and Pancreatic Cancer Data for STimulator of INterferon Genes (STING) Agonist Published in Two Scientific Journals